Cardiac contractility modulation and subcutaneous defibrillator (S-ICD): First experience with simultaneous...

Area of Science:

• Cardiology
• Medical Technology

Background:

• Advanced heart failure (HF) with reduced left ventricular ejection fraction (LVEF) presents complex management challenges.
• Cardiac contractility modulation (CCM) and subcutaneous implantable cardioverter-defibrillators (S-ICD) are distinct therapeutic technologies for HF.
• The combination of CCM and S-ICD in a single patient has not been widely explored.

Observation:

• A case report details a 51-year-old male patient with reduced LVEF (33%) and a narrow QRS complex.
• The patient underwent a simultaneous implantation procedure for both CCM and S-ICD devices.
• This represents a novel application of combining these two advanced cardiac technologies.

Findings:

• The simultaneous implantation of CCM and S-ICD was technically successful in the reported case.
• The combined therapy was feasible for a patient with advanced HF and reduced LVEF.
• This approach offers a potential solution for managing complex HF patients.

Implications:

• Simultaneous CCM and S-ICD implantation may offer a consolidated treatment strategy for select advanced HF patients.
• This combined approach could lead to significant clinical symptom improvement in a single surgical intervention.
• Further research is warranted to evaluate the long-term efficacy and safety of combined CCM and S-ICD therapy.